The S&P 500 healthcare sector saw a negative total return of 0.2% in September, making it the worst-performing sector when compared to the overall S&P 500 Index, which recorded a gain of 1.9% in the market, according to data compiled by S&P Global Market Intelligence.
Financials stock led the gains in the S&P 500 Index in September, with a total return of 4.6%, followed by S&P 500 Utilities with a gain of 4.3%.
![]() |
Perrigo Co. PLC was the only healthcare company among the top 10 performers on the S&P 500 Index based on total gains for September. Placed at seventh, the Dublin-based pharmaceutical company saw a gain of 19.5%.
Tapestry Inc. and Capri Holdings Ltd. topped the charts with a total return of 28% and 25.7%, respectively.
![]() |
AbbVie Inc., the manufacturer of blockbuster drug Humira, was the second-best performer in the healthcare sector on the S&P 500 Index, with a return of 15.2%.
Of the 62 healthcare companies on the S&P 500 Index as of the end of September, only four reported double-digit gains for the month. Other top performers in the healthcare sector were Varian Medical Systems Inc. and Cardinal Health Inc. with total returns of 12.4% and 10.5%, respectively.
![]() |
MarketAxess Holdings Inc. had the highest negative return on the S&P 500 Index with a 17.6% loss for September.



